Literature DB >> 19618240

Vagal nerve function in obesity: therapeutic implications.

John G Kral1, Wencesley Paez, Bruce M Wolfe.   

Abstract

The primal need for nutrients is satisfied by mechanisms for sensing internal stores and detecting food; ATP is the most primitive signal. With increasing density of sensory neurons and glia (the primordial brain) and the emergence of autonomic neural activity throughout the endoderm, transmitters and other signaling molecules enable alimentation before the appearance of innate storage functions. Memory and, ultimately, cognition are prerequisites for processing and producing food to facilitate assimilation and safeguard the supply of nutrients. The gut-brain-gut axis via the vagus nerve is the autonomic neurohumoral pathway integrating these elements of energy homeostasis. Humans uniquely override obligate nutrient needs, eating in the absence of deprivation, resulting in pathological chronic overnutrition arising from dysautonomia. Obesity surgery circumvents powerful redundant mechanisms of alimentation and reduces excess stores of body fat from chronic overnutrition while preventing re-accumulation of fat. All bariatric operations, whether purely restrictive, maldigestive and malabsorptive, or combinations, rely on regulatory mechanisms related to autonomic nervous system function and the brain-gut axis. We review the functional anatomy and the importance of the vagus nerve for maintaining maladaptive chronic overnutrition and describe interventions to abrogate its effects. In aggregate, the preponderance of evidence supported by laboratory and clinical mechanistic studies interrupting abdominal bi-directional vagal transmission demonstrates that the majority of patients report less "hunger" and lose weight.

Entities:  

Mesh:

Year:  2009        PMID: 19618240     DOI: 10.1007/s00268-009-0138-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  99 in total

Review 1.  Adrenergic receptor polymorphisms and autonomic nervous system function in human obesity.

Authors:  Koichiro Yasuda; Tetsuro Matsunaga; Tetsuya Adachi; Norihiko Aoki; Gozoh Tsujimoto; Kinsuke Tsuda
Journal:  Trends Endocrinol Metab       Date:  2006-07-21       Impact factor: 12.015

2.  One-year experience with Tantalus: a new surgical approach to treat morbid obesity.

Authors:  Arthur Bohdjalian; Gerhard Prager; Ricardo Aviv; Shai Policker; Karin Schindler; Silke Kretschmer; Raphaela Riener; Johannes Zacherl; Bernhard Ludvik
Journal:  Obes Surg       Date:  2006-05       Impact factor: 4.129

3.  Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms.

Authors:  D A Towler; C E Havlin; S Craft; P Cryer
Journal:  Diabetes       Date:  1993-12       Impact factor: 9.461

Review 4.  Vagal mechanisms in appetite regulation.

Authors:  J G Kral
Journal:  Int J Obes       Date:  1981

5.  Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial.

Authors:  Scott A Shikora; Richard Bergenstal; Marc Bessler; Fred Brody; Gary Foster; Arthur Frank; Mark Gold; Samuel Klein; Robert Kushner; David B Sarwer
Journal:  Surg Obes Relat Dis       Date:  2008-10-01       Impact factor: 4.734

6.  Ghrelin acts in the central nervous system to stimulate gastric acid secretion.

Authors:  Y Date; M Nakazato; N Murakami; M Kojima; K Kangawa; S Matsukura
Journal:  Biochem Biophys Res Commun       Date:  2001-01-26       Impact factor: 3.575

7.  An improved technique for laparoscopic highly selective vagotomy using harmonic shears.

Authors:  N Katkhouda; D J Waldrep; G M Campos; E Tang; S Offerman; A P Trussler; J Gugenheim; J Mouiel
Journal:  Surg Endosc       Date:  1998-08       Impact factor: 4.584

8.  Long-term outcome of vagus nerve stimulation therapy in patients with refractory epilepsy.

Authors:  Abuhuziefa Abubakr; Ilse Wambacq
Journal:  J Clin Neurosci       Date:  2008-02       Impact factor: 1.961

9.  Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device.

Authors:  M Camilleri; J Toouli; M F Herrera; B Kulseng; L Kow; J P Pantoja; R Marvik; G Johnsen; C J Billington; F G Moody; M B Knudson; K S Tweden; M Vollmer; R R Wilson; M Anvari
Journal:  Surgery       Date:  2008-05-09       Impact factor: 3.982

10.  Quantitative positron emission tomography studies of the serotonin transporter in humans previously treated with the appetite suppressants fenfluramine or dexfenfluramine.

Authors:  Una D McCann; Zsolt Szabo; Melin Vranesic; Esen Seckin; Gary Wand; Anna Duval; Robert F Dannals; George A Ricaurte
Journal:  Mol Imaging Biol       Date:  2007 May-Jun       Impact factor: 3.484

View more
  19 in total

1.  Cranial Nerves IX, X, XI, and XII.

Authors:  Paulette Marie Gillig; Richard D Sanders
Journal:  Psychiatry (Edgmont)       Date:  2010-05

Review 2.  The Role of the Vagal Nucleus Tractus Solitarius in the Therapeutic Effects of Obesity Surgery and Other Interventional Therapies on Type 2 Diabetes.

Authors:  Claudio Blasi
Journal:  Obes Surg       Date:  2016-12       Impact factor: 4.129

Review 3.  Effects of vagal neuromodulation on feeding behavior.

Authors:  Nicole A Pelot; Warren M Grill
Journal:  Brain Res       Date:  2018-02-07       Impact factor: 3.252

Review 4.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 5.  How and why do gastrointestinal peptides influence food intake?

Authors:  Stephen C Woods; Aaron A May-Zhang; Denovan P Begg
Journal:  Physiol Behav       Date:  2018-03-22

Review 6.  Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.

Authors:  Joanna K Soczynska; Sidney H Kennedy; Hanna O Woldeyohannes; Samantha S Liauw; Mohammad Alsuwaidan; Christina Y Yim; Roger S McIntyre
Journal:  Neuromolecular Med       Date:  2010-12-17       Impact factor: 3.843

Review 7.  Vagal afferent controls of feeding: a possible role for gastrointestinal BDNF.

Authors:  Edward A Fox
Journal:  Clin Auton Res       Date:  2012-06-21       Impact factor: 4.435

Review 8.  Cholinergic modulation of food and drug satiety and withdrawal.

Authors:  Nicole M Avena; Pedro V Rada
Journal:  Physiol Behav       Date:  2012-03-28

Review 9.  Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity.

Authors:  D Val-Laillet; E Aarts; B Weber; M Ferrari; V Quaresima; L E Stoeckel; M Alonso-Alonso; M Audette; C H Malbert; E Stice
Journal:  Neuroimage Clin       Date:  2015-03-24       Impact factor: 4.881

Review 10.  Effects of GLP-1 on appetite and weight.

Authors:  Meera Shah; Adrian Vella
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.